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Isolation of peptides from phage-displayed random peptide libraries that
interact with the talin-binding domain of vinculin
Nils B. ADEY* and Brian K. KAY†
Department of Biology, University of North Carolina, Chapel Hill, NC 27599-3280, U.S.A.
Peptides isolated from combinatorial libraries typically interact
with, and thus help to characterize, biologically relevant binding
domains of target proteins. To characterize the binding domains
of the focal adhesion protein vinculin, vinculin-binding peptides
were isolated from two phage-displayed random peptide libraries.
Altogether, five non-similar vinculin-binding peptides were
identified. Despite the lack of obvious sequence similarity be-
tween the peptides, binding and competition studies indicated
that all five interact with the talin-binding domain of vinculin
and do not disrupt the binding of α-actinin or paxillin to
vinculin. The identified peptides and talin bind to vinculin in a
comparable manner; both bind to immobilized vinculin, but
INTRODUCTION
At the cytoplasmic face of the cell membrane, focal adhesions
anchor integrins to the actin cytoskeleton. A number of focal
adhesion-associated proteins have been identified, including α-
actinin, focal adhesion kinase, paxillin, talin, tensin, vinculin and
zyxin. Molecular interactions between these proteins have been
proposed to regulate cell adhesion and modulate such processes
as cell growth, differentiation, wound healing and tumour
metastasis [1–5]. In this study we have used peptides isolated
from phage-displayed random peptide libraries to investigate the
protein–protein interactions of the focal adhesion protein
vinculin. Central to this strategy is the observation that peptides
isolated by affinity selection from such libraries typically interact
with biologically relevant domains of the target proteins [6,7].
For example, peptides selected with antibodies [8–11], strep-
tavidin [12], Src [13–16], integrins [17], calmodulin [18,19] or
receptors [20] have been shown to be either antagonists or
agonists of these proteins.
We have identified five different peptide sequences from phage-
displayed random peptide libraries that bind to the cytoskeletal
protein vinculin. Gel overlay experiments of proteins present in
cell lysates revealed that the peptides are highly specific for
vinculin. To dissect the binding of the peptides to vinculin we
performed saturation mutagenesis on one sequence and identified
three motifs important for vinculin binding. Binding studies
showed that the peptides interact with the talin-binding domain
of vinculin in a manner comparable to talin. Use of these
peptides in intact cells, either as blocking reagents or as fusions
to other proteins to impart novel functions, should provide a
wealth of additional information.
MATERIALS AND METHODS
Materials
General biochemical reagents were obtained from Sigma Chemi-
Abbreviations used: GST, glutathione S-transferase ; SaAP, streptavidin-conjugated alkaline phosphatase.
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neither binds to soluble vinculin unless the C-terminus of vinculin
has been deleted. An analysis of amino acid variants of one of the
peptides has revealed three non-contiguous motifs that also
occur in the region of talin previously demonstrated to bind
vinculin. Amino acid substitutions within a 127-residue segment
of talin capable of binding vinculin confirmed the importance of
two of the motifs and suggest that residues critical for binding
are within a 16-residue region. This study demonstrates that the
vinculin-binding peptides interact with vinculin in a biologically
relevant manner and represent an excellent tool for further study
of the biochemistry of vinculin.
cal Company (St. Louis, MO, U.S.A.). Vinculin, talin, paxillin
and α-actinin were purified to various degrees by DEAE-cellulose
column chromatography of chicken gizzard extracts, as pre-
viously described [21]. Peptides (pC, pV, pVR and pT) were
synthesized by standard fluoren-9-ylmethoxycarbonyl chemistry
by Dr. J. Mark Carter (Cytogen Corporation, Princeton, NJ,
U.S.A.), with biotin added to their N-termini.
Screening of phage-displayed random peptide libraries
Vinculin (1 µg) was adsorbed on non-adjacent wells of a 96-well
polystyrene mictotitre plate, non-specific binding sites were
blocked with 1.0% (w}v) BSA, and then 10"" phage particles in
wash buffer [PBS (pH 7.5)}0.1% Tween-20}0.1% BSA] were
incubated for 4 h at room temperature. Two bacteriophage M13
libraries, displaying either 22 [15] or 26 [19] random amino acid
residues at the N-terminus of protein III, were screened for
vinculin-binding phages. Non-bound phages were removed from
the wells by repeated washes and the bound phages were eluted
with 50 mM glycine}HCl, pH 2.0. After neutralization of the
pH, the recovered phages were amplified in DH5αF« Escherichia
coli cells for 6 h; the resulting phages were screened two
additional times. The recovered phages were finally plated at a
limiting concentration to yield individual plaques for clonal
analysis [22].
Quantification of phage–vinculin and peptide–vinculin interactions
Plaques, representing single clones, were amplified in DH5αF«
cells and the resulting phage particles were evaluated for binding
to vinculin-coated microtitre plate wells by ELISA, using a
horseradish peroxidase-coupled anti-M13 antibody in accord-
ance with the manufacturer’s instructions (Pharmacia, Piscat-
away,NJ,U.S.A.). The sequences of the phage-displayed peptides
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were deduced by sequencing both DNA strands of the ap-
propriate region in the viral genome.
For the detection of peptide–vinculin interactions on mem-
branes, protein samples were resolved by SDS}PAGE, trans-
ferred to PVDF membranes (Millipore, Bedford, MA, U.S.A.),
blocked with 0.1% poly(vinyl alcohol) and then incubated with
individual peptides precomplexed with streptavidin-conjugated
alkaline phosphatase (SaAP) in wash buffer. The membranes
were washed four times (15 min each at room temperature) ;
bound SaAP–peptide complexes were detected with Nitroblue
Tetrazolium chloride and 5-bromo-4-chloro-3-indoyl phosphate
p-toluidine salt in 0.1 M Tris}HCl (pH 9.4)}0.1 M NaCl}50 mM
MgCl
#
. A similar protocol was used to monitor peptide–vinculin
interactions in microtitre plate wells, except that alkaline phos-
phatase activity was detected with p-nitrophenyl phosphate and
measured spectrophotometrically.
Expression and purification of glutathione S-transferase
(GST)–vinculin fusion proteins
The plasmids V1-252, V1-430, V811-1066 and V1-1066 (gifts
from Dr. Susan Craig, Johns Hopkins University, Baltimore,
MD, U.S.A.) and V431-850 (constructed in the same manner)
were transformed into E. coli LE392 cells, grown to mid-
exponential growth phase, and expression of the fusion protein
was induced with 0.05% isopropyl β--thiogalactoside for 4 h.
The GST fusion proteins were purified by affinity chromat-
ographywith glutathione–agarose and recovered by either throm-
bin cleavage or glutathione elution [23].
Phage binding and competition experiments
Interactions between isolated phages and vinculin were mon-
itored by coating microtitre plates wells with vinculin (see above)
and following the binding of phage particles by ELISA (see
above). For competition studies on the interaction, wells were
preincubated in wash buffer containing the appropriate peptide
(10 µM) for 10 min before the addition of phage particles. The
binding of various cytoskeletal proteins to immobilized vinculin
was determined in a similar manner except that protein fractions
from an anion-exchange column (see above) enriched for in-
dividual chicken gizzard proteins (approx. 2 µg per well) were
added instead of phage particles. The binding of these proteins
was followed immunologically with a polyclonal anti-talin anti-
body (gift from Dr. Keith Burridge, University of North Carolina
at Chapel Hill, Chapel Hill, NC, U.S.A.), a monoclonal anti-
paxillin antibody (Transduction Labs, Lexington, KY, U.S.A.)
or a polyclonal anti-α-actinin antibody (Sigma) and detected
with the appropriate alkaline phosphatase-linked secondary
antibodies.
Detection of peptide–vinculin interactions in solution
Biotinylated peptide (0.3 µg) was incubated with approx. 2 µg of
purified protein in 0.5 ml of wash buffer for 1 h at room
temperature. Peptide–protein complexes were recovered by incu-
bating the mixtures for 30 min with 10 µl of streptavidin-coated
magnetic beads (PerSeptive Diagnostics, Cambridge, MA,
U.S.A.). The beads were washed once in wash buffer and once in
PBS}0.1% Tween-20; the bound proteins were then eluted at
100 °C in 20 µl of gel-loading dye [24]. The beads were removed
by centrifugation and the proteins in the supernatant were
resolved by SDS}PAGE [8% (w}v) gel] and detected by
Coomassie Blue staining.
Binding studies with wild-type and mutant segments of mouse
talin
Segments of mouse talin were generated by PCR from a mouse
fibroblast cDNA library (gift from Dr. Terry Van Dyke, Uni-
versity of North Carolina at Chapel Hill, Chapel Hill, NC,
U.S.A.) and cloned into the SP35T vector, which contains the 5«
and 3« untranslated sequences of rabbit β-globin mRNA and an
SP6 RNA polymerase promoter. [$&S]Methionine-labelled talin
fragments were expressed in itro in a transcription-coupled
translation expression system in accordance with the manu-
facturer’s instructions (Promega, Madison, WI, U.S.A.). Site-
directed mutagenesis was performed as described [25]. To micro-
titre plate wells coated with vinculin, wild-type and mutant talin
fragments translated in itro were added in wash buffer. After 4 h
of incubation the wells were washed and the contents removed
with gel-loading buffer for evaluation by SDS}PAGE and
quantification with a PhosphorImager (Molecular Dynamics,
Sunnyvale, CA, U.S.A.). A more detailed description is
available via the Internet (http:}}www.unc.edu}depts}biology}
kayref.html).
RESULTS
Isolation of vinculin-binding phages from random peptide libraries
To identify peptides that bound to the focal adhesion protein
vinculin, bacteriophage M13 libraries displaying 22- and 26-
residue random peptides were screened by affinity selection.
After three rounds of screening with microtitre plate wells coated
with chicken gizzard vinculin, recovered phages were isolated,
amplified and their binding properties evaluated. The phage
isolates seemed to bind specifically to vinculin and not to a
variety of other proteins (results not shown). Sequence analysis
of the isolates showed that they displayed one of five different
peptides, without obvious sequence similarity (Figure 1).
Competition of peptide with talin for binding to vinculin
Vinculin interacts with a number of focal adhesion-associated
proteins including α-actinin [26,27], actin [28,29], paxillin [30,31],
talin [32,33], tensin [34] and itself [32]. To evaluate whether the
peptides interacted with vinculin in a biologically relevant
manner, a competition experiment was performed to determine
whether a vinculin-binding peptide could disrupt the interaction
Figure 1 Amino acid sequences of vinculin-binding peptides
Vinculin-binding phages were isolated from the T12 (Vin.12-1) and the R26 (Vin.26b-2, Vin.26d-
1, Vin.26d-2 and Vin.26d-3) random peptide libraries displayed at the N-terminus of protein III
of bacteriophage M13. Single underlined positions indicate residues that were fixed in each
library. Residues shown in bold indicate sequence motifs shared with talin (see Figure 6).
Phages Vin.26b-2 and Vin.26d-1 are shorter than Vin.26d-2 and Vin.26d-3 owing to single-
residue deletions, which most probably occurred during assembly and cloning of the
oligonucleotides. The sequence labelled Vin.12-1R corresponds to an amino acid variant of
Vin.12-1 with improved binding properties, where the central glycine residue has been replaced
by arginine (double underline).
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Figure 2 pV, the peptide displayed by Vin.12-1, competes with talin, but not paxillin or α-actinin, in binding vinculin
Chicken vinculin was immobilized on microtitre plate wells, preincubated with competitor peptide and then incubated with chromatographic fractions containing talin, paxillin or α-actinin. After
repeated washes, the amount of protein bound to the wells was determined with the appropriate primary and enzyme-linked secondary antibodies. (a) peptide pV (biotin-
STGGFDDVYDWARGVSSALTTTLVATR) (5 µM) disrupts the talin–vinculin interaction but not the paxillin–vinculin or the α-actinin–vinculin interactions. The same concentration of an unrelated
competitor peptide, pC (biotin-STVPRWIEDSLRGGAARAQTRLASATR), had no effect. (b) pV and pVR (biotin-STGGFDDVYDWARRVSSALTTTLVATR) compete with talin for binding to immobilized
vinculin in a concentration-dependent manner. The average of two independent determinations is plotted ; the range is indicated by error bars.
Figure 3 All five peptides recognize the same site on vinculin
The vinculin-binding phages were examined for binding to various segments of vinculin by
ELISA. Segments of vinculin [residues 1–252 (8), 1–430 (9), 431–850 (6), 811–1066
(:) and 1–1066 (5)] were expressed in E. coli as GST fusion proteins [49]. +, Full-length
vinculin isolated from chicken gizzard. 7, Wells preincubated with 10 µM pVR before the
addition of phages. (Binding was not affected by preincubation with a similar amount of the
unrelated peptide pC.) Column heights represent the average relative spectrophotometric signal
of three separate determinations, with the error bars representing the range. The values were
adjusted by subtracting the background signal from BSA-coated wells and scaling the values
to that of the chicken-gizzard vinculin samples.
of vinculin with any of these cytoskeletal proteins. Protein
preparations enriched for talin, paxillin or α-actinin were added
to microtitre plate wells containing immobilized vinculin and the
amount of bound talin, paxillin or α-actinin was determined by
ELISA. Figure 2(a) shows that a peptide (pV), corresponding to
the insert of phage Vin.12-1, disrupts the interaction of vinculin
with talin but not with paxillin or α-actinin. We interpret this
result to suggest that the peptide binds at or near the talin-
binding domain of vinculin and not to the sites where paxillin
and α-actinin bind.
Localization of peptide-binding sites on vinculin
To map the binding site(s) of the five phages, we evaluated their
binding to different segments of vinculin. As seen in Figure 3,
three of the phages bound to every fragment that contained
the N-terminal 252 amino acid residues, corresponding to the
talin-binding domain of vinculin [3,35]. Whereas the two other
phages bound immobilized vinculin, they did not bind to any of
the E. coli-expressed fragments (Figure 3). A single amino acid
variant (see below) of the peptide sequence displayed by phage
Vin.12-1 was found to promote binding to vinculin fragments.
When the soluble form of this peptide (pVR) was added to the
microtitre wells, it was observed to be an effective inhibitor of
binding of all five phages to full-length vinculin. In contrast,
pVR did not disrupt the paxillin–vinculin or the α-actinin–
vinculin interactions (results not shown). We conclude that all
five vinculin-binding phages bind to the same general site in
vinculin.
Identification of amino acid substitutions in pV that affect binding
to vinculin
To determine which amino acid residues in the pV sequence
contribute to vinculin-binding, a library displaying 10' variants
of the Vin.12-1 peptide was constructed [36]. The phage-display
system is a useful one for generating and evaluating the binding
properties of amino acid variants [37,38]. Phage isolates were
selected at random from the library, tested for binding to
immobilized vinculin and sequenced. Single amino acid sub-
stitutions that disrupted binding tended to occur throughout the
length of the peptide, whereas most non-disruptive substitutions
were clustered at the N-terminus (Figure 4). These results indicate
that a significant portion of the peptide sequence is involved in
vinculin binding.
To identify improved binding peptides from the library of
variants, the evolved library was subjected to one round of
screening with a decreased amount of vinculin immobilized on
microtitre plates. A number of recovered phages were confirmed
to have improved binding strength to vinculin. Sequence analysis
of those isolates revealed that amino acid substitutions occurred
at a small number of positions, of which the most common was
the replacement of the central fixed glycine residue (Figure 1) by
an arginine (e.g. Vin.12-1R, pVR).
The concentration dependence of the peptides pV and pVR on
the disruption of the talin–vinculin interaction was determined.
Figure 2(b) shows that pVR is a more potent inhibitor than pV,
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Figure 4 Saturation mutagenesis of the pV sequence
A library of phages displaying amino acid variants of the pV peptide was constructed according
to published procedures [36]. Phage isolates were picked at random, sequenced and tested for
binding to vinculin in microtitre plate wells by ELISA. Isolates classified as ‘ binders ’ produced
a signal at least half as strong as the original Vin.12-1 phage, whereas ‘ non-binders ’ produced
a signal one-tenth as strong as the parent clone. To identify improved binding peptides, the
library was subjected to one round of affinity selection with a small of amount of vinculin
(0.05 µg per well) and output clones were tested as described above. Most isolates from this
screen produced signals up to 5-fold stronger than that of the parent phage. The peptide
displayed by improved binding phage, Vin.12-1R (pVR), is used in several experiments in this
paper. Primary structures of the various peptides are shown relative to pV (bottom) : full points
indicate identity, amino acid differences are indicated with capital letters, asterisks indicate silent




of approx. 100 nM. This result supports the
observation that the glycine–arginine substitution in Vin.12-1
improves the apparent binding strength of the peptide to vinculin.
Detection of vinculin in a cell lysate with a vinculin-binding
peptide
To examine the specificity of the peptide–vinculin interaction,
whole-cell lysates from chicken embryo fibroblast cells were
resolved by SDS}PAGE, transferred to a PVDF membrane and
incubated with SaAP complexed to pVR (Figure 5). The comp-
lexed peptide reacted strongly with a 130 kDa species, with no
observable cross-reactivity with any other protein (lane 2). This
species is likely to be vinculin, as demonstrated by positive
reaction with purified vinculin in other blots (results not shown).
The binding of the pVR peptide to the 130 kDa is saturable, as
its detection can be competed by excess pVR. These results
demonstrate that peptides can be used as detection reagents in a
gel overlay.
Interaction of the vinculin-binding peptide with soluble vinculin
Although a strong interaction between the vinculin-binding
peptides and immobilized vinculin is readily observed, we were
unable to detect an interaction between the peptides and soluble
vinculin (results not shown). To investigate this paradox, we
tested whether the peptides could bind soluble fragments of
vinculin expressed in E. coli. Figure 5 demonstrates that only
proteolytically truncated fragments of vinculin bind to the pVR
peptide. Because vinculin is fused at its N-terminus to GST, the
proteolytic fragments that are purified by glutathione–agarose
chromatography are probably truncated at the C-terminus. These
results, consistent with previous studies [39], indicate that the C-
Figure 5 pVR peptide recognizes vinculin in gel overlays and in solution
A whole-cell lysate from chicken embryo fibroblast cells was resolved by SDS/PAGE and
revealed by Coomassie Blue staining (lane 1). The same lysate was also transferred to a PVDF
membrane by standard blotting techniques. The immobilized proteins were detected with pVR
precomplexed to SaAP and then revealed with the chromogenic reagents Nitro Blue Tetrazolium
and 5-bromo-4-chloro-3-indolyl phosphate (lane 2). In lane 3 the blot was pretreated with a 100-
fold excess of pVR peptide precomplexed to streptavidin ; this treatment blocks the interaction
of pVR precomplexed to SaAP, as detected with Nitro Blue Tetrazolium and 5-bromo-4-chloro-
3-indolyl phosphate. Lanes 4–8 represent samples resolved by SDS/PAGE and stained with
Coomassie Blue. Lane 8 contains bacterially expressed vinculin fragments from the full-length
vinculin GST fusion construct, V1-1066. These proteolytically cleaved fragments were truncated
at their C-termini because only fragments fused to the N-terminal GST protein would be
recovered by glutathione–agarose chromatography. Lanes 4–7 are the subset of those
fragments recovered with streptavidin-coated magnetic beads after incubation in solution with
biotinylated pV peptide and (lane 4) no additional peptide, (lane 5) a 100-fold excess of non-
biotinylated pV, (lane 6) a 100-fold excess of an unrelated non-biotinylated peptide pC, or (lane
7) an unrelated biotinylated peptide pC. The band common to lanes 4–8 is BSA, as it was
present in the wash solution.
terminus of vinculin interacts with the talin-binding domain in
the N-terminus and excludes binding of the pVR peptide.
Sequence comparison of the vinculin-binding peptides with known
vinculin-binding proteins
Although there is little sequence similarity between the five
vinculin-binding peptides, sequence comparisons between the
peptides and talin revealed two segments of similarity (Figure 6).
The first segment is composed of two five-residue peptide motifs :
LTTTL from Vin.12-1 and VEDLT from Vin.26d-1 matched
residues 1807–1814 (VEDLTTTL) from talin [40]. The second
segment is composed of five- and three-residue peptide motifs
(DVY and ARRVS, both in Vin.12-1R, termed the DVY}
ARRVS motif), which occurred within a 16-residue segment of
talin.
To determine whether the motifs shared by talin and the
phages are involved in binding vinculin, a number of experiments
were performed. First, a short peptide of talin (pT), containing
the sequence VEDLTTTL, was synthesized and found not to
bind either immobilized or soluble vinculin (results not shown).
Secondly, segments of the mouse talin cDNA were amplified by
PCR, cloned and expressed in itro. The resulting 378-residue
(1702–2079) and 127-residue (1891–2017) fragments of talin,
termed Tal378 and Tal127 respectively, had the capacity to bind
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Figure 6 Mouse talin, sites of oligonucleotides for PCR amplification,
sequence motifs and sites of mutations
Segments of the mouse talin coding [40] were amplified by PCR from a mouse fibroblast cDNA
library by using the oligonucleotides 1702 and 2079, or 1891 and 2017 (numbers correspond
to the positions of the amino acid residues encoded by the oligonucleotides, underlined). These
segments, encoding 378- and 127-residue fragments of mouse talin respectively, were cloned
and expressed in vitro in a transcription-coupled translation system to generate the 35S-labelled
Tal378 and Tal127 polypeptides (see Table 1). Residues in bold type correspond to the three
motifs described in the text present in several of the vinculin-binding phages. Amino acid
substitutions incorporated into the Tal127 fragments are shown within a 16-residue region
(double underline), generating the ∆AFSI polypeptide.
Table 1 Relative binding of [35S]Met-labelled talin fragments translated
in vitro to immobilized vinculin
Bound products were eluted with SDS/dithiothreitol, resolved by electrophoresis and quantified
with a Phosphorimager. Abbreviation : n.d., not done.
Relative binding (%)
Competitor peptide (5 µM)
Mutation
Talin fragment None pVR pT ∆AFSI
Tal378 100 14 101 n.d.
Tal127 100 9 118 32*
* Average of three independent determinations.
immobilized vinculin. Their binding, however, could be blocked
with the pVR, but not the pT (biotin-SGSGRTEAVEDLTTTL-
NEAASK), peptide (Table 1). Thirdly, to assess the significance
of the DVY}ARRVS motif, site-directed mutagenesis was used
to create four amino acid substitutions within the motif. This
mutant form of the 127-residue segment, termed ∆AFSI, showed
decreased binding, suggesting that the DVY}ARRVS motif of
talin is involved in binding to vinculin.
DISCUSSION
In this study, five peptides were isolated from phage-displayed
random peptide libraries that bound to the focal adhesion
protein vinculin. Binding and competition experiments showed
that all five peptides interacted with the talin-binding domain of
vinculin. Curiously, the peptides lacked sequence similarity. This
finding is reminiscent of the discovery of mimotopes [41], where
short peptides bind to the antigen-binding site of antibodies even
though they differ in sequence from the antigen. Presumably
either the tertiary structures of the five peptides are similar, even
though their primary structures differ, or the five peptides bind
at neighbouring sites on vinculin.
The inability of the vinculin-binding peptides to disrupt the
interaction of vinculin with α-actinin or paxillin suggests that
these interactions occur at distinct sites. This result is consistent
with previous studies that mapped vinculin’s α-actinin-, talin-
and paxillin-binding domains to the N-terminal 107 [27] and 252
amino acid residues [35,42] and to the C-terminus [43] re-
spectively. Our work extends these results by demonstrating that
talin and α-actinin bind vinculin at distinct sites.
A particularly interesting finding of this study was that
although the peptides could bind immobilized vinculin they did
not seem to bind full-length vinculin in solution. However, if the
C-terminus was truncated from soluble vinculin, their binding
was restored. These results are consistent with previous studies
showing that both the talin-and actin-binding domains of vinculin
are masked by an intramolecular interaction between the N- and
C-termini [39,44] and that the conformation of vinculin is
regulated biologically between the ‘open’ and ‘closed’ states by
PtdIns(4,5)P
#
[45]. We hypothesize that when vinculin is adsorbed
on surfaces (microtitre dish or PVDF membranes) it adopts an
open state that is competent to bind talin or our peptides.
A detailed analysis of one of the vinculin-binding peptides first
drew our attention to two sequence motifs (DVY}ARRVS and
VEDLTTTL), present in the peptide and talin, as being po-
tentially important for binding. However, we later found that a
127-residue fragment of talin (1891–2017) that contained the
DVY}ARRVS, but not the VEDLTTTL, motif was still capable
of binding to vinculin and that a peptide corresponding to the
VEDLTTTL motif region of talin was not an effective competitor
of the talin–vinculin interaction. Mutation of the DVY}ARRVS
motif in talin, in contrast, diminished binding to vinculin. Thus
it seems that a 16-residue region of talin (1948–1963) is critical in
binding vinculin. This result is consistent with previous work [46]
that mapped a vinculin-binding domain of talin to residues
1328–2268 and recent work [46a] that narrowed this domain to
residues 1929–2029. Additional work will be needed to delineate
the details of themolecular interaction between talin and vinculin,
as this general region is not well conserved in sequence between
mouse and nematode talin [47], and other experiments [48] with
an anti-idiotype antibody mapped the vinculin-binding domain
of talin to residues 1653–1848, which contains the VEDLTTTL
motif, but not to the DVY}ARRVS motif.
The vinculin-binding peptides represent an excellent tool for
further study of the biochemistry of vinculin. The peptides could
be used as detection reagents, in both ELISA and in gel overlay
formats. In addition, the peptides can be used to differentiate
between open and closed conformations of vinculin. It will be
interesting in the future to express such sequences in io as a
potential means of disrupting the talin–vinculin interaction or to
target fusion proteins to the talin-binding domain of vinculin.
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